购物车
全部删除
您的购物车当前为空
P2Y14R antagonist 5 (Compound A) 是一种具有苯并异噁唑骨架的新型P2Y14R拮抗剂,其IC50为23.60 nM,KD为7.26 μM。此化合物可显著降低促炎因子(如IL-1β、IL-6、TNF-α)和髓过氧化物酶(MPO)的水平。在LPS诱导的急性肺损伤小鼠模型中,P2Y14R antagonist 5 表现出良好的抗炎活性。
P2Y14R antagonist 5 (Compound A) 是一种具有苯并异噁唑骨架的新型P2Y14R拮抗剂,其IC50为23.60 nM,KD为7.26 μM。此化合物可显著降低促炎因子(如IL-1β、IL-6、TNF-α)和髓过氧化物酶(MPO)的水平。在LPS诱导的急性肺损伤小鼠模型中,P2Y14R antagonist 5 表现出良好的抗炎活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
P2Y14R antagonist 5 相关产品
| 产品描述 | P2Y14R antagonist 5 (Compound A) is a novel P2Y14R antagonist with a benzisoxazole-based structure, exhibiting an IC50 of 23.60 nM and a KD of 7.26 μM. This compound can reduce levels of pro-inflammatory factors (IL-1β, IL-6, TNF-α) and myeloperoxidase (MPO). It demonstrates anti-inflammatory activity in a mouse model of LPS-induced acute lung injury. |
| 靶点活性 | P2Y14 Receptor:23.60 nM |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容